Eli Lilly resubmitted an application for U.S. Food and Drug Administration (FDA) approval in June 2009 for the treatment of chronic pain with Cymbalta (duloxetine). Cymbalta is already approved for the treatment of depression, anxiety, fibromyalgia, and diabetic neuropathy.
OrganizedWisdom.com exists to organize data and to present it in a format which informs and educates.
All tools developed at OrganizedWisdom.com seek to organize data in the public sphere or help others to organize their own data.
Data is most palatable when it is organized, simplified and visualized.
2014 © OrganizedWisdom.com ALL Rights Reserved.